Get started
RocketTickers

Myovant Sciences Announces FDA Approval of ORGOVYX™ (relugolix),

Long
RocketTickers  
NYSE:MYOV   None
Beyond Technical Analysis
1
0
beyondta
MYOV: Myovant Sciences, Inc.
2020-12-18 16:49:37
Myovant Sciences Announces FDA Approval of ORGOVYX™ (relugolix), the First and Only Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.